(Q34458362)

2 August 2017

1 reference

title

Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

Gobburu JV

1

1 reference

PubMed ID

11735607

2 August 2017

Marroum PJ

series ordinal

2

1 reference

2 August 2017

1 January 2001

1 reference

Clinical Pharmacokinetics

2 August 2017

1 reference

2 August 2017

40

1 reference

2 August 2017

12

1 reference

2 August 2017

883-892

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200140120-00001

2 August 2017

0 references

cites work

A simulation study comparing designs for dose ranging

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic modeling in vivo

1 reference

12 December 2020

Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine

1 reference

12 December 2020

Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific Agents

1 reference

12 December 2020

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

12 December 2020

Modeling markers of disease progression by a hidden Markov process: application to characterizing CD4 cell decline

1 reference

12 December 2020

Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: A use of bootstrap standard error

1 reference

12 December 2020

A regulatory perspective on pharmacokinetic/pharmacodynamic modelling

1 reference

12 December 2020

Role of dosage regimen in controlling indirect pharmacodynamic responses

1 reference

12 December 2020

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans

1 reference

12 December 2020

Evaluation of designs for clinical trials of neuroprotective agents in head injury. European Brain Injury Consortium.

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

1 reference

12 December 2020

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

1 reference

12 December 2020

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

12 December 2020

Population pharmacokinetics. A regulatory perspective.

1 reference

12 December 2020

Simulation of clinical trials

1 reference

12 December 2020

Kinetics of antimicrobial action

1 reference

12 December 2020

Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations

1 reference

12 December 2020

Kinetics of pharmacologic effects

1 reference

12 December 2020

Evaluation of bioequivalence of highly variable drugs using Monte Carlo simulations. I. Estimation of rate of absorption for single and multiple dose trials using Cmax

1 reference

12 December 2020

Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach

1 reference

12 December 2020

A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity

1 reference

12 December 2020

Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin

1 reference

12 December 2020

Stability and performance of a population pharmacokinetic model

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic modeling in drug development

1 reference

12 December 2020

A mixture model for longitudinal data with application to assessment of noncompliance

1 reference

12 December 2020

10.2165/00003088-200140120-00001

Identifiers

DOI

1 reference

PubMed ID

11735607

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11735607